Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials

AIMS: Intermittent levosimendan administration has been suggested to improve survival in patients with advanced heart failure (AdHF). Quality of life is a key issue for AdHF patients and is negatively affected by frequent hospitalizations. METHODS AND RESULTS: CENTRAL, Google Scholar, MEDLINE/PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvetti, Simona, Belletti, Alessandro, Fontana, Antonella, Pollesello, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695198/
https://www.ncbi.nlm.nih.gov/pubmed/28834396
http://dx.doi.org/10.1002/ehf2.12177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695198/
https://www.ncbi.nlm.nih.gov/pubmed/28834396
http://dx.doi.org/10.1002/ehf2.12177

Ejemplares similares